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The c-ret gene encodes a receptor tyrosine kinase (RET) essential for the development of the kidney and enteric nervous
system. Activation of RET requires the secreted neurotrophin GDNF (glial cell line-derived neurotrophic factor) and its high
affinity receptor, a glycosyl phosphatidylinositol-linked cell surface protein GFR1. In the developing kidney, RET, GDNF,
and GFR1 are all required for directed outgrowth and branching morphogenesis of the ureteric bud epithelium. Using
MDCK renal epithelial cells as a model system, activation of RET induces cell migration, scattering, and formation of
filopodia and lamellipodia. RET-expressing MDCK cells are able to migrate toward a localized source of GDNF. In this
report, the intracellular signaling mechanisms regulating RET-dependent migration and chemotaxis are examined.
Activation of RET resulted in increased levels of phosphatidylinositol 3-kinase (PI3K) activity and Akt/PKB phosphoryla-
tion. This increase in PI3K activity is essential for regulating the GDNF response, since the specific inhibitor, LY294002,
blocks migration and chemotaxis of MDCK cells. Using an in vitro organ culture assay, inhibition of PI3K completely
blocks the GDNF-dependent outgrowth of ectopic ureter buds. PI3K is also essential for branching morphogenesis once the
ureteric bud has invaded the kidney mesenchyme. The data suggest that activation of RET in the ureteric bud epithelium
signals through PI3K to control outgrowth and branching morphogenesis. © 2002 Elsevier Science (USA)
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The c-ret protooncogene encodes a protein (RET) of the
receptor tyrosine kinase gene superfamily with a character-
istic extracellular ligand-binding domain, a transmembrane
domain, and a cytoplasmic tyrosine kinase domain. The
c-ret gene is essential for normal embryonic development of
the kidney and enteric nervous system and has also been
associated with at least three kinds of neoplasias. In hu-
mans, RET loss-of-function results in Hirschsprung disease,
a deficiency of neurons in the enteric nervous system of the
gastrointestinal tract (Edery et al., 1994; Romeo et al.,
1994). Constitutively active RET causes multiple endocrine
neoplasia types 2A and 2B (MEN2A, MEN2B) and familial
medullary thyroid carcinoma (FMTC) (Carlson et al., 1994;
Hofstra et al., 1994; Mulligan et al., 1993; Santoro et al.,
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1281995). Activation of the RET catalytic domain is thought to
require binding of glial cell-derived neurotrophic factor
(GDNF) to a high affinity receptor, GFR1 (Jing et al., 1996;
Treanor et al., 1996), which interacts with the RET extra-
cellular domain.
Genetic analyses in mice clearly indicate that RET,
GDNF, and GRF1 are each essential for development of
the mammalian kidney. Kidney development is a sequen-
tial process that begins with formation of the nephric duct,
which extends from the midthoracic region to the cloaca of
the embryo (for review, see Davies and Bard, 1998; Lechner
and Dressler, 1997). The metanephric kidney is formed at
the posterior end of the nephric duct as the ureteric bud, an
outgrowth or diverticulum, extends from the duct and
invades a group of surrounding cells, the metanephric
mesenchyme. RET is expressed along the entire nephric
duct (Pachnis et al., 1993), whereas GDNF is expressed in
the adjacent metanephric mesenchyme (Hellmich et al.,
1996). A high percentage of mice homozygous for null
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mutations of RET exhibit renal agenesis, because the ure-
teric bud does not extend at all from the nephric duct
(Schuchardt et al., 1994, 1996). In those Ret mutants that do
show some degree of ureteric bud growth, there is a block in
branching morphogenesis. However, mesenchyme from the
RET-knockout mice can support growth and branching of a
wild-type ureter in culture and are also able to differentiate
into epithelium when induced with wild-type ureteric bud.
Both GDNF- and GFR1-null mutant mice exhibit com-
plete ablation of the ureteric bud (Cacalano et al., 1998;
Moore et al., 1996; Pichel et al., 1996; Sanchez et al., 1996),
whereas ectopic GDNF can stimulate ureteric bud branch-
ing morphogenesis in organ culture (Sainio et al., 1997;
Vega et al., 1996). Thus, both genetic and biochemical
analyses are consistent with the hypothesis that the RET/
GDNF/GFR1 signaling complex regulates the migration
and/or proliferation of the renal epithelial cells that will
generate the ureteric buds, its branches, and the mature
collecting duct system.
How the RET protein transduces the signals to mediate
growth and invasion remains obscure. Because the signaling
complex requires both GDNF and GFR1, it has proved
difficult to study RET activation in a ligand-dependent
manner. As a result, much of the early available evidence
regarding downstream signaling was obtained with chi-
meric RET proteins or oncogenic, constitutively active
forms of RET. The adaptor protein Shc binds activated RET
upon phosphorylation of tyrosine 1062 (Arighi et al., 1997)
and is necessary for mitogenic activity (Durick et al., 1995,
1998). The enigma protein, which contains a PDZ domain
and three LIM domains, also binds to tyrosine 1062 but only
if it is phosphorylated (Durick et al., 1996, 1998). The
ability of oncogenic RET to transform cells also requires a
docking site for phospholipase C at tyrosine 1015 (Borrello
et al., 1996). More recently, ligand-dependent activation of
RET in neuroblastoma cells, which express GFR1, results
in increased phosphotidylinositol 3-kinase (PI3K) activity
and the phosphorylation of proteins located at the focal
adhesion complex, including focal adhesion kinase (FAK),
paxillin, and p130Cas (Murakami et al., 1999). The MEN2A
form of oncogenic RET can activate PI3K, apparently also
through tyrosine 1062, resulting in activation of Akt/PKB
and phosphorylation of forkhead transcription factors
(Segouffin-Cariou and Billaud, 2000). Although tyrosine
1062 appears essential for transformation and mitogenesis,
it is unclear whether wild-type RET mediates cell prolifera-
tion in vivo, particularly in the developing urogenital sys-
tem. At least seven other tyrosine residues can be phosphor-
ylated in the activated form of RET (Liu et al., 1996), the
significance of which remain unclear.
The migration and invasion of ureteric bud epithelium
into the adjacent metanephric mesenchyme is an example
of chemotaxis at the tissue level. Using MDCK renal
epithelial cells expressing RET, we have previously shown
that GDNF promotes cell scattering, the extension of
lamellipodia and filopodia, and increased cell motility
(Tang et al., 1998). RET-expressing epithelial cells are able
to migrate toward a localized source of GDNF. Thus,
GDNF may be a target-derived guidance cue for the ureteric
bud epithelium. Cell motility is dependent, in part, on
reorganization of the cytoskeleton, which can be mediated
by PI3K (Fruman et al., 1998; Wennstrom et al., 1994). In
this report, the RET-expressing MDCK cells are used to
address the role of PI3K in epithelial cell migration and
ureteric bud outgrowth. Ligand activation of RET in MDCK
cells results in increased PI3K activity and increased phos-
phorylation of Akt/PKB, whereas inhibition of PI3K
blocked GDNF-dependent cell migration. Furthermore, we
demonstrate that PI3K is essential for mediating GDNF-
dependent ureteric bud outgrowth and branching morpho-
genesis in kidney organ cultures. Inhibitors of the ERK1/2
and p38 MAP kinase pathways did not grossly affect initial
ureteric bud outgrowth, suggesting that these pathways are
not essential for transducing RET signaling in the develop-
ing ureteric bud epithelia. However, p38 inhibitors did
affect branching morphogenesis at later stages and may
indicate a role for this MAPK in regulating the site or
number of branch points. Our results point to an essential
role for PI3K in epithelial cell scattering, invasion, and
branching morphogenesis in the developing kidney.
MATERIALS AND METHODS
Cell Lines and Organ Culture
RET-transfected MDCK cells were maintained in Dulbecco’s
modified Eagles medium (DMEM; glucose concentration: 450 mg/
dL) supplemented with 10% fetal bovine serum, 100 U/ml penicil-
lin, and 100 g/ml streptomycin under humidified 5% CO2/95%
air at 37°C. Single cell suspension was obtained by incubating the
monolayer culture in 0.05% trypsin solution. For determination of
cell number, suspended cells were counted with a hemocytometer
in the presence of trypan blue.
Timed matings were set up with the day of the vaginal plug
designated as E0.5. Organ culture was done in 6-well plates using
0.4-micron Transwell inserts and DMEM supplemented with 10%
fetal calf serum. For the bead experiments, heparin acrylamide
beads (Sigma, St. Louis, MO) were incubated in 10 ng/l of
recombinant GDNF (Promega Corp., Madison, WI) or BSA for 1 h
on ice and washed briefly in PBS before placing on organ cultures.
Whole-mount antibody staining of organ cultures was done as
described (Cho et al., 1998). Briefly, tissues were fixed in methanol
for 10 min and washed two times for 10 min in PBS, 0.1% Tween
20 (PBST). Anti-Pax2 (0.5 mg/ml) and anti-Pan-cytokeratin (Sigma;
1:50) antibodies were diluted in PBST, 2% goat serum and incu-
bated for 3–4 h at 4°C. Tissues were washed in PBST four times for
1 h each with one wash overnight at 4°C. The second antibodies,
FITC-anti-mouse (Sigma) and TRITC-anti-rabbit (Sigma), were
used at 1:100 dilution in PBST, 2% goat serum and incubated for
3 h. After extensive washing, the samples were placed on slides and
covered with gelvatol.
PI3K Activity Assay
Subconfluent cells were cultured in DMEM containing 10%
serum with or without 100 ng/ml of soluble, recombinant human
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GFR1 (gift of M. Sanicola, Biogen Inc., Cambridge, MA) and 50
ng/ml of recombinant human GDNF for 20 h. Cells were washed
with phosphate-buffered saline (PBS), and lysed in IP-lysis buffer
(20 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 2.5 mM sodium
pyrophosphate, 1 mM sodium orthovanadate, 1 mM PMSF, 1
g/ml leupeptin, and 1% NP-40). The lysate was incubated with 5
l of anti-PI3K p85 (Santa Cruz Corp., Santa Cruz, CA) antibody for
3 h at 4°C. The immunocomplexes were collected with 50 l
Protein-A agarose and washed twice with lysis buffer and then once
with reaction buffer (10 mM MgCl2, 50 mM Tris, pH 7.4). The
immunoprecipitates were suspended in 50 l of reaction buffer
containing phosphatidylinositol (PI), phosphatidylserine (PS) (PI
and PS were both dissolved in 20 mM Hepes, pH 7.4, 1 mM EDTA),
and 10 Ci [-32P]ATP and were incubated for 20 min at room
temperature. The reaction was terminated by adding 100 l of 1 N
HCl. The products were first extracted with 160 l chloroform/
methanol (1:1) and then with 80 l methanol: 100 mM HCl, 2 mM
EDTA (1:1). Thin-layer chromatography silicon plates were pre-
coated with 1% potassium oxalate and 2 mM EDTA in H2O/MeOH
(3:2) at room temperature for 30 min and air-dried overnight. The
products were separated in a running buffer of chloroform/
methanol/NH4OH/H2O (43:38:5:1.5; vol/vol) by thin-layer chro-
matography on silicon plates. Radioactive phosphatidylinositol
phosphate (PIP) was detected by autoradiography.
Immunoblotting
Cells were lysed in IP-lysis buffer at and cleared by centrifuga-
tion and protein levels quantified by the Bio-Rad colorometric
assay. SDS/PAGE sample buffer (6) was added, and samples were
boiled for 5 min. Samples were run on a 7.5% polyacrylamide gel,
transferred to PVD membrane, and blocked with 5% milk in
Tris-buffered saline. Membranes were immunoblotted with anti-p-
Akt antibody, anti-Akt, and anti-pERK1/2 (Cell Signaling Tech-
nologies, Beverly, MA) in 10 mM Tris, pH 7.5, 100 mM NaCl, 0.1%
Tween 20, 1% nonfat milk. Secondary antibodies conjugated to
horseradish peroxidase were used at a 1:10,000 dilution, and the
signal was visualized by enhanced chemiluminescence (Amer-
sham, Piscataway, NJ) using recommended protocols.
Cell Migration and Chemotaxis Assay
For migration assays, cells from monolayer cultures were treated
with 0.2% trypsin/EDTA, washed once with 10% serum media,
and resuspended in 10% serum media. The migration assay was
performed by using a 48-well modified Boyden chamber (Neuro-
Probe Inc., Rockville, MD) with the lower chambers filled with
10% serum media containing GDNF (50 ng/ml) and GFR1 (100
ng/ml). Collagen-coated polycarbonate filters with 8-m pores
were used as the membranes separating upper and lower chambers.
Each well was plated with 50 l suspended cells (5  105/ml) and
the Boyden chamber was incubated at 37°C in 5% CO2. After 20 h,
cells on the upper surface of the membrane were removed by using
a cotton swab. The membrane was then fixed with methanol for 8
min and stained with Giemsa. The cells on the lower surface were
counted under light microscope at high-power magnification
(400). Multiple fields (four to eight) were counted.
RESULTS
Previously, we characterized stably transformed MDCK
cell lines expressing wild-type RET or kinase-deficient
mutants (Tang et al., 1998). The Ret9 cell line expresses
full-length 1115 amino acid form of the human RET pro-
tein, whereas the Km line expresses a point mutant of RET
that alters the ATP-binding site within the kinase domain.
In response to GDNF and soluble GFR1, activated RET
promotes cell scattering and chemotaxis of Ret9 cells to a
localized source of GDNF. Cell scattering, migration, and
chemotaxis are mediated in part by the reorganization of
the cytoskeleton. PI3K is known to regulate the rearrange-
ment of the cytoskeleton (Khwaja et al., 1998) and is
activated upon HGF-induced cell motility (Derman et al.,
1995). To determine whether PI3K functions in GDNF/
RET-induced cell motility and chemotaxis, in vitro PI3K
assays were done with Ret9 and Km cells (Fig. 1). Increase in
PI3K activity was already apparent 1 h after GDNF treat-
ment, with a peak activity at 12 h post-GDNF addition (Fig.
1A). In long-term stimulation assays (Fig. 1B), only Ret9
cells showed an increase in steady-state PI3K activity of
four- to fivefold, whereas Km cells had no response to
GDNF.
Since activation of PI3K leads to phosphorylation of
Akt/PKB, we examined levels of phospho-Akt with specific
antibodies (Fig. 2). In Ret9 cells, an increase in levels of
phospho-Akt could be discerned in as little as 15 min after
GDNF/GFR1 treatment. Over time, levels of phospho-Akt
increased significantly, whereas the total levels of Akt were
unaffected. To examine activation of the MAP kinase
pathway, levels of phospho-ERK1/2 were examined. While
there was a slight increase in phospho-ERK1/2 after 15 min
and a peak at 30 min, phospho-ERK levels were not sus-
tained. Thus, activation of RET in response to ligands
results in a fourfold increase in PI3K activity and an
approximate 8- to 10-fold increase in activated Akt.
To confirm that PI3K was essential for GDNF/RET-
induced cell motility and chemotaxis of Ret9 cells, the
specific PI3K inhibitor LY294002 was used in the transfilter
migration assay (Fig. 3). Cells were seeded as a monolayer
on top of a Transwell insert and GDNF/GFR1 was added
to the bottom, or basal side, of the dish. In a dose-response
experiment (data not shown), the migration capacity of
Ret9 cells was reduced to base line levels by LY294002 at a
concentration of 10 M. At this concentration, Ret9 cells
all showed a significant reduction in RET-mediated trans-
filter migration ability (Fig. 3). The effect of PI3K inhibition
on cell proliferation was negligible as the numbers of cells
migrating through the filter in the absence of GDNF were
similar to that of control media. The specific MAPK inhib-
itor PD98059 had little effect on the mobility of Ret9 cells
in response to GDNF/GFR1 (data not shown). Thus, the
PI3K appears to be the predominant signaling pathway
required for migration and chemotaxis, in response to
ligand activation of RET in renal epithelial cells.
Given the requirement for PI3K in our model system of
epithelial cell chemotaxis, we next examined whether PI3K
was necessary for the outgrowth of the ureteric bud. Ectopic
ureteric bud outgrowth can be observed in an organ culture
system in response to GDNF (Brophy et al., 2001; Sainio et
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al., 1997). The region of intermediate mesoderm, contain-
ing both nephric ducts, the mesonephric tubules, and the
posterior periductal mesenchyme, was dissected from E10.5
mouse embryos and laid flat on a Transwell filter. Heparin
acrylamide beads were soaked in GDNF and placed along
the midline, between the bilateral nephric ducts of the
cultures. Normally, the ureteric buds grow laterally into
the metanephric mesenchyme, at the posterior end of the
FIG. 1. Activation of PI3K in Ret9 cells. Subconfluent RET-expressing MDCK cell lines were incubated with or without GDNF/GFR1,
and immunoprecipitates were assayed for PI3K activity. (A) Time course of PI3K activation in Ret9 cells is shown. Activities were
calculated relative to the basal PI3K activity prior to addition of GDNF/GFR1. (B) Graph shows PI3K activity 20 h after addition of ligands
GDNF/GFR1 (G) in Ret9 and Km cells. A Western blot is shown below to demonstrate that equal amounts of immunoprecipitated p85
were used for the PI3K assay. The bars show the mean of three independent experiments  standard deviation.
FIG. 2. Phosphorylation of Akt in Ret9 cells. Western blot analyses
of protein lysates from Ret9 cells in response to GDNF/GFR1.
Antibodies used are as indicated. Lysates were prepared at time 0 with
no added GDNF, and at 15, 30, 60, and 90 min after addition of RET
ligands. Note the rapid induction of phospho-Akt, with no increase in
total Akt present. A transient increase in phospho-ERK1/2 is also
observed with a peak at about 30 min after GDNF addition.
FIG. 3. Transfilter chemotaxis assay with inhibition of PI3K by
LY294002. Ret9 cells were assayed in the Boyden chamber chemo-
taxis assay in the presence or absence of 10 M LY294002 and 50
ng/ml GDNF. The bars represent the mean number of cells migrating
through the filter over a given area  1 standard deviation. Note that
LY294002 alone has little effect on base line migration.
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intermediate mesoderm. However, GDNF beads can pro-
mote budding of the nephric duct epithelial toward the
midline at more anterior positions (Fig. 4). Using the
formation of ectopic ureteric buds as a biological readout for
RET activation and signaling, the effects of various inhibi-
tors were examined. Neither the MEK1 inhibitor PD98059
(10 M) nor the p38 MAP kinase inhibitor SB203580 (20
M) significantly reduced the ability of GDNF to promote
budding, as in the controls, 4/4 cultures showed ectopic
ureteric buds. However, the formation of ectopic ureteric
buds from the nephric duct epithelial was completely
inhibited by the LY294002 (20 M) in all cultures exam-
ined. Indeed, the PI3K inhibitor also blocked formation of
the endogenous ureteric buds at the posterior aspect. Cells
adjacent to the posterior nephric ducts still expressed the
Pax2 gene, as did the nephric duct epithelial cells, indicat-
ing no gross effects on cell viability.
To examine the effect of PI3K inhibition on branching
morphogenesis, we cultured E11.5 metanephric kidneys on
Transwell filters with the same inhibitors as above (Fig. 5).
Strikingly, we observed a complete inhibition of branching
in the presence of 20 M LY294002, whereas 10 M
PD98059 had no significant effect on branching of the
ureteric bud epithelia, condensation of the mesenchyme, or
epithelial conversion. Inhibition of the p38 MAP kinase did
have some effects on the branching pattern of the ureteric
bud epithelia. In the presence of 20 M SB203580, ureteric
bud branches were elongated and appeared less dichoto-
mous; mesenchyme aggregation and epithelial conversion
were unaffected. The effects of the specific inhibitors were
examined by Western blotting of protein lysates from E11.5
kidney rudiments cultured for 48 h (Fig. 6). Incubation with
10 M PD98059 resulted in a near complete inhibition of
ERK1/2 phosphorylation as determined by Western blotting
with anti-phospho-ERK antibodies, yet there was little
effect on the expression of phospho-AKT. In the presence of
20 M LY294002, however, expression of phospho-ERK was
unaffected and the levels of phospho-AKT were reduced
FIG. 4. Induction of ureteric bud outgrowth requires PI3K. The region of intermediate mesoderm was dissected from E10.5 embryos and
grown on a Transwell filter. Heparin acrylamide beads soaked in GDNF (*) were placed along the midline, between the two bilateral nephric
ducts. Cultures were grown for 24 h and then stained with antibodies against cytokeratin (green) and Pax2 (red). In control cultures, note
the position of ectopic ureteric buds growing toward the bead (arrowheads). Inhibition of MEK1 (10 M PD98059) or p38 MAP kinase (20
M SB203580) had little effect on GDNF-mediated ureteric bud outgrowth in four separate cultures. However, in four independent cultures,
no evidence of budding was seen with the addition of 20 M LY294002. Magnification bar is 200 microns for all panels.
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approximately three- to fourfold, as determined by densi-
tometer scanning. To test the efficacy of the p38 MAPK
inhibitor, we tried immunoblotting for phospho-ATF2, a
target of the p38 kinase. However, we were unable to detect
this protein in control or treated organ cultures. The com-
plete block of branching morphogenesis observed upon
inhibition of PI3K was not due to cell death, as the mesen-
chymal aggregates continued to express Pax2, showed acti-
vation of E-cadherin and cadherin-6 expression, and showed
expression of phosho-ERK. The initial mesenchymal aggre-
gates began the process of epithelial conversion; however,
no new aggregates were induced due to the lack of branch-
ing morphogenesis and subsequent induction.
DISCUSSION
The embryonic kidney arises from two main cell types:
the ureteric bud epithelium and the metanephric mesen-
chyme. Outgrowth of the ureteric bud epithelium and
invasion into the metanephric mesenchyme depends on
GDNF activation of the RET receptor tyrosine kinase. In
this report, we demonstrate that GDNF-dependent ureteric
bud outgrowth is mediated by the PI3K pathway. These
conclusions are based on the following observations. Using
our MDCK model system, recombinant GDNF and GFR1
can activate RET, resulting in increased levels of PI3K
activity. This is accompanied by rapid elevation of
phospho-Akt, a downstream target of PI3K. GDNF-
dependent migration and chemotaxis of Ret9 cells is com-
pletely blocked by the PI3K inhibitor LY294002. Using an
embryonic organ culture system, GDNF can induce ectopic
ureteric bud outgrowth from the nephric duct epithelia,
also in a PI3K-dependent manner. Furthermore, inhibitors
of the ERK1/2 or p38 MAP kinases at concentrations used
in this study had little effect on the initial GDNF-mediated
ureteric bud outgrowth in our organ culture system.
Branching morphogenesis of the ureteric bud epithelia was
affected by p38 inhibition at later developmental stages and
suggests a role for this MAPK in branch point patterning.
These results suggest that increased levels of PI3K in
response to RET activation is a necessary signaling mecha-
nism mediating chemotaxis of the renal epithelial cells.
The signaling mechanisms of RET-mediated cell sur-
FIG. 5. Inhibition of branching morphogenesis with LY294002. Embryonic kidney rudiments were dissected from E11.5 embryos and
cultured for 48 h in control media or in the presence of 10 M PD98059, SB203580, or LY294002. Cultures were stained by whole-mount
immunocytochemistry with the indicated antibodies. Anti-Pax2 stains the condensed mesenchyme and the ureteric bud branches, whereas
anti-cytokeratin only stains the ureteric bud branches. Top panel shows that inhibition of MEK1 (PD98059, ERK1/2 pathway) had no
significant effect on branching of the ureteric bud or on induction and condensation of the mesenchyme. Inhibition of p38 MAP kinase
(SB203580) did not completely block branching of the ureteric bud, but did result in elongated branches with fewer branch points.
Magnification bar is 50 microns for all top panels. In the lower panel, inhibition of PI3K (LY294002) completely blocked ureteric bud
branching but did not prevent aggregation of the mesenchyme, as evidenced by Pax2 and cadherin-6 expression (arrows). Magnification bars
are 500 and 200 microns, as indicated.
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vival, chemotaxis, and oncogenesis have been studied in a
variety of systems. We believe that activation of PI3K is a
direct response to RET activation, because: (1) Inhibition of
PI3K in both MDCK cells and organ culture blocks RET-
dependent chemotaxis; (2) PI3K activity and AKT phosphor-
ylation are relatively rapid responses to RET activation; and
(3) The activation of PI3K and a direct interaction with RET
have been reported in other cell types. Activation of PI3K
has been observed in GDNF-dependent neuronal survival
(Besset et al., 2000; Encinas et al., 2001) and in HGF-
mediated MDCK cell scattering (Khwaja et al., 1998). PI3K
activity has also been linked to the transforming ability of
the c-ret oncogene, through a docking site at tyrosine 1062
(Segouffin-Cariou and Billaud, 2000). Besset et al. (2000)
describe increased PI3K activity in RET/GFR1-transfected
NIH3T3 cells upon GDNF stimulation that was mediated
by two potential docking sites, tyrosines 1062 and 1096, at
least one of which interacts with the insulin receptor
substrate IRS1 (Melillo et al., 2001a). The 1062 tyrosine
residue has also been implicated in activation of MAP
kinase pathways, through binding of FRS2 (Melillo et al.,
2001b), in oncogenic forms of RET. Thus, it is not surpris-
ing that PI3K is also required for mediating the GDNF/RET
signal in the ureteric bud epithelium. However, these
results do not preclude the possibility that PI3K is indi-
rectly by RET. Nevertheless, its activity is essential for
controlling the biological response to the RET/GDNF/
GFR1 signaling pathway.
Our experiments with the Ret9 MDCK cell derivatives
utilize a soluble form of the Gpi-linked GFR1 high affinity
receptor. This soluble form increases GDNF/GFR1-
mediated signaling in neuronal cell lines and alters the
kinetics of lipid raft formation to produce a more prolonged
response (Paratcha et al., 2001). Similarly, the MDCK cell
migration assay may also exhibit a more robust response in
our experiments, as the soluble GFR1 signals in trans.
Thus, we have utilized an organ culture assay, where
GFR1 is expressed in cis by the ureteric bud epithelium, to
confirm the role of PI3K in ureteric bud outgrowth. Nor-
mally, GFR1 is expressed by both metanephric mesen-
chyme and ureteric bud epithelia (Sainio et al., 1997). Our
bead experiments would suggest that expression of GFR1
by the epithelia is sufficient to mediate a GDNF-dependent
response, although expression and release of GFR1 by the
mesenchyme may potentiate this response in vivo. In
neuronal cells, GDNF/GFR1 stimulates both cell spread-
ing and neurite outgrowth, which can be blocked by the
PI3K and MEK1 inhibitors (Paratcha et al., 2001). Thus,
PI3K appears to be a common target of activated RET in
both neurons and the ureteric bud epithelia.
While we were not surprised to see a dramatic effect of
PI3K inhibitor on branching morphogenesis, the role of
ERK1/2 was less clear. Phosphorylation of ERK1/2 by the
upstream kinase MEK1 has been linked to RET activation
in a variety of cell types and is thought to be important for
oncogenic RET activity. We also see a transient increase in
ERK phosphorylation in the Ret9 cells, although basal
levels are already quite high. Thus, it was surprising to see
that 10 M PD98059 had little effect on the outgrowth of
ectopic ureteric buds in response to the GDNF beads, nor
did it inhibit branching morphogenesis in whole kidney
cultures. This is in direct contrast to a recent report
showing a reduction in branching morphogenesis with 10
M and complete inhibition by 25 M PD98059 (Fisher et
al., 2001). Given the normal morphology observed in our
assay, it was important to show a lack of ERK1/2 phosphor-
ylation. Even at 10 M PD98059, levels of phospho-ERK1/2
were undetectable whereas levels of phospho-Akt are unaf-
fected. At present, it is difficult to reconcile these differ-
ences, though subtle differences in culture conditions may
play a role. Given the transient increase in ERK phosphor-
ylation observed in the MDCK cells, it is also possible that
the time of explant may account for some of the reported
differences.
Within the context of the developing urogenital system,
ectopic GDNF is sufficient to induce ureteric bud out-
growth from the posterior nephric duct epithelia (Brophy et
al., 2001; Sainio et al., 1997). The expression of GDNF in
the metanephric mesenchyme is activated by the Pax2
protein, whereas GDNF activity is suppressed by BMP4
(Brophy et al., 2001; Miyazaki et al., 2000) though it is not
clear whether this is due to suppression of RET signaling. In
vitro, MDCK renal epithelial cells that express RET are able
to migrate toward a source of GDNF (Tang et al., 1998). In
order for epithelial cells to migrate in vivo, a delicate
balance between cell motility and maintenance of cellular
junctions must be preserved. Thus, signaling through the
FIG. 6. Western blotting for p-ERK and p-AKT. E11.5 kidney
rudiments were cultured for 48 h in control media () or in 10 M
PD98059 () or 20 M LY294002 (). Total protein lysates were
separated by SDS/PAGE and probed with antibodies against
phospho-ERK1/2 and phospho-AKT as indicated. Note the p-ERK
panel for PD98059 was deliberately overexposed to show minimal
expression of p-ERK upon treatment. Equal amounts of protein
were loaded in each lane as evidenced by equal expression of p-AKT
in the PD98059 panels and p-ERK in the LY294002 panels.
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RET protein must allow for cell movement without de-
stroying the essential nature of the epithelial sheet. The
migration of cells requires the reorganization of the actin
cytoskeleton, the formation of cellular processes, such as
lamellipodia and filopodia, and the association of focal
adhesion complexes (Cooper, 1991), as is observed upon
RET activation in Ret9 cells (Tang et al., 1998). The
extension of cellular processes may be essential for chemo-
taxis as local concentrations of ligands are sensed to induce
directional migration. Moreover, PI3K has been implicated
in the regulation of the actin cytoskeleton by growth factors
such as PDGF and insulin (Kotani et al., 1994; Nobes et al.,
1995; Wennstrom et al., 1994) and in MDCK cells upon
HGF-induced cell scattering (Khwaja et al., 1998; Ridley et
al., 1995). How PI3K transduces the GDNF/RET mediated
chemotactic response of renal epithelial cells remains to be
clarified. However, it appears likely that reorganization of
the cytoskeleton and formation of cellular processes
through activation of downstream effectors of PI3K, such as
Akt, FAK, and paxillin, will be essential.
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